BioCentury
ARTICLE | Company News

MorphoSys, University of Texas MD Anderson Cancer Center deal

May 30, 2016 7:00 AM UTC

MorphoSys and MD Anderson Cancer Center partnered to use MorphoSys’ Ylanthia technology to discover and develop antibodies against undisclosed targets selected by both parties to treat cancer. Both pa...